Search Results

Filter
  • 1-10 of  97,032 results for ""HYDROCHLOROTHIAZIDE""

Your Filters

Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Use of Hydrochlorothiazide in the United States Following Label Update About Skin Cancer Risk.

  • Authors : Chen C; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, Maryland, USA.; Eworuke E

Subjects: Hydrochlorothiazide*/Hydrochlorothiazide*/Hydrochlorothiazide*/adverse effects ; Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/epidemiology ; Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/chemically induced

  • Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Oct; Vol. 33 (10), pp. e70040.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic)

Record details

×
Academic Journal

Changes in the Use of Hydrochlorothiazide and Other Antihypertensive Drugs in Switzerland in Association With the Swissmedic Safety Alert Regarding Non-melanoma Skin Cancer: An Interrupted Time-Series Analysis Using Swiss Claims Data.

  • Authors : Zappalà T; Basel Pharmacoepidemiology Unit, Division of Clinical Pharmacy and Epidemiology, Department of Pharmaceutical Sciences, University of Basel, Basel, Switzerland.; Pottegård A

Subjects: Hydrochlorothiazide*/Hydrochlorothiazide*/Hydrochlorothiazide*/adverse effects ; Antihypertensive Agents*/Antihypertensive Agents*/Antihypertensive Agents*/adverse effects ; Interrupted Time Series Analysis*

  • Source: Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2024 Sep; Vol. 33 (9), pp. e70005.Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic)

Record details

×
Academic Journal

Preferred diuretic therapy for primary hypertension: Chlorthalidone or hydrochlorothiazide?

  • Authors : Young TD; Trevor D. Young practices in outpatient internal medicine at Baylor Scott & White Health, Central Texas Region in Temple, Tex., and is an adjunct professor and clinical assistant professor in the University of Mary Hardin-Baylor Physician Assistant Program in Belton, Tex. The author has disclosed no potential conflicts of interest, financial or otherwise.

Subjects: Chlorthalidone*/Chlorthalidone*/Chlorthalidone*/administration & dosage ; Chlorthalidone*/Chlorthalidone*/Chlorthalidone*/therapeutic use ; Hydrochlorothiazide*/Hydrochlorothiazide*/Hydrochlorothiazide*/administration & dosage

  • Source: JAAPA : official journal of the American Academy of Physician Assistants [JAAPA] 2024 Aug 01; Vol. 37 (8), pp. 1-2. Date of Electronic Publication: 2024 Jul 25.Publisher: Wolters Kluwer Country of Publication: United States NLM ID: 9513102 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Geographical Differences in Hydrochlorothiazide Associated Risk of Skin Cancer Balanced Against Disability Related to Hypertensive Heart Disease.

Subjects: Hydrochlorothiazide*/Hydrochlorothiazide*/Hydrochlorothiazide*/adverse effects ; Hydrochlorothiazide*/Hydrochlorothiazide*/Hydrochlorothiazide*/therapeutic use ; Skin Neoplasms*/Skin Neoplasms*/Skin Neoplasms*/epidemiology

  • Source: American journal of hypertension [Am J Hypertens] 2024 Oct 14; Vol. 37 (11), pp. 924-932.Publisher: Oxford University Press Country of Publication: United States NLM ID: 8803676 Publication Model: Print Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Analytical QbD for the optimization of a multimode HPLC method for the investigation of hydrochlorothiazide, diltiazem and propranolol release from 3D printed formulation.

  • Authors : Samara IM; Laboratory of Pharmaceutical Analysis, Department of Pharmacy, Aristotle University of Thessaloniki, GR-54124, Greece.; Ntorkou M

Subjects: Hydrochlorothiazide*/Hydrochlorothiazide*/Hydrochlorothiazide*/analysis ; Hydrochlorothiazide*/Hydrochlorothiazide*/Hydrochlorothiazide*/chemistry ; Printing, Three-Dimensional*

  • Source: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2024 Sep 15; Vol. 248, pp. 116324. Date of Electronic Publication: 2024 Jun 24.Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Resolution of overlapping spectra using chemometric manipulations of UV-spectrophotometric data for the determination of Atenolol, Losartan, and Hydrochlorothiazide in pharmaceutical dosage form.

  • Authors : Hassan OB; Faculty of Biotechnology, October University for Modern Sciences and Arts (MSA), Giza 12451, Egypt.; ELkady EF

Subjects: Hydrochlorothiazide*/Hydrochlorothiazide*/Hydrochlorothiazide*/analysis ; Atenolol*/Atenolol*/Atenolol*/analysis ; Losartan*/Losartan*/Losartan*/analysis

  • Source: Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy [Spectrochim Acta A Mol Biomol Spectrosc] 2024 Oct 05; Vol. 318, pp. 124471. Date of Electronic Publication: Publisher: Elsevier Country of Publication: England NLM ID: 9602533 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-3557

Record details

×
Academic Journal

Highly sensitive voltammetric determination of hydrochlorothiazide using a glassy carbon electrode modified with Super P carbon black nanoparticles.

  • Authors : Santos-Neto DR; Department of Chemical Technology, Federal University of Maranhão, 65080-805, São Luís, Maranhão, Brazil. .; Lopes CEC

Subjects: Hydrochlorothiazide*/Hydrochlorothiazide*/Hydrochlorothiazide*/analysis ; Hydrochlorothiazide*/Hydrochlorothiazide*/Hydrochlorothiazide*/urine ; Hydrochlorothiazide*/Hydrochlorothiazide*/Hydrochlorothiazide*/chemistry

  • Source: Analytical methods : advancing methods and applications [Anal Methods] 2024 Sep 19; Vol. 16 (36), pp. 6271-6278. Date of Electronic Publication: 2024 Sep 19.Publisher: RSC Pub Country of Publication: England NLM ID: 101519733 Publication Model: Electronic Cited Medium: Internet ISSN: 1759-9679

Record details

×
Academic Journal

Risk assessment based on spectrophotometric signals used in eco-friendly analytical scenarios for estimation of carvedilol and hydrochlorothiazide in pharmaceutical formulation.

  • Authors : Nabil M; Pharmaceutical Chemistry Department, Faculty of Pharmacy, Future University in Egypt, Cairo, 11835, Egypt.; Marzouk HM

Subjects: Carvedilol*/Carvedilol*/Carvedilol*/analysis ; Hydrochlorothiazide*/Hydrochlorothiazide*/Hydrochlorothiazide*/analysis ; Spectrophotometry*/Spectrophotometry*/Spectrophotometry*/methods

  • Source: Scientific reports [Sci Rep] 2024 Aug 23; Vol. 14 (1), pp. 19657. Date of Electronic Publication: 2024 Aug 23.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Acute Declines in Estimated Glomerular Filtration Rate in Patients Treated With Benazepril and Hydrochlorothiazide Versus Amlodipine and Risk of Cardiovascular Outcomes.

  • Authors : Ku E; Division of Nephrology, Department of Medicine University of California San Francisco CA.; Department of Epidemiology & Biostatistics University of California San Francisco CA.

Subjects: Amlodipine*/Amlodipine*/Amlodipine*/therapeutic use ; Amlodipine*/Amlodipine*/Amlodipine*/adverse effects ; Hydrochlorothiazide*/Hydrochlorothiazide*/Hydrochlorothiazide*/therapeutic use

  • Source: Journal of the American Heart Association [J Am Heart Assoc] 2024 Aug 06; Vol. 13 (15), pp. e035177. Date of Electronic Publication: 2024 Jul 26.Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Evaluation of Drug-Drug Interaction Between Henagliflozin and Hydrochlorothiazide in Healthy Chinese Volunteers.

  • Authors : Chen Q; Center Laboratory, Shanghai Xuhui Central Hospital, Shanghai, People's Republic of China.; Shanghai Engineering Research Center of Phase I Clinical Research & Quality Consistency Evaluation for Drugs, Shanghai, People's Republic of China.

Subjects: Drug Interactions* ; Healthy Volunteers* ; Hydrochlorothiazide*/Hydrochlorothiazide*/Hydrochlorothiazide*/administration & dosage

  • Source: Drug design, development and therapy [Drug Des Devel Ther] 2024 May 29; Vol. 18, pp. 1855-1864. Date of Electronic Publication: 2024 May 29 (Print Publication: 2024).Publisher: Dove Press Limited Country of Publication: New Zealand NLM ID: 101475745 Publication Model: eCollection Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  97,032 results for ""HYDROCHLOROTHIAZIDE""